Replies to post #789092 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

seekazy,

“1,000 clinical trials” 😶

Yes, you & LP both have wise foresight to make reference to the thundering heard…



The vastly growing research interest that you’re referring to is not all about cancer vaccines specifically, but you’re right to highlight the broad & growing interest in dendritic cell technologies. DC products could have applications beyond oncology, including organ transplants, autoimmune diseases, HIV, & other diseases.

The expansive possibilities are intriguing:



“Building a Leading Dendritic Cell Franchise”

[Investor082]

I agree. Without reimbursement support from NICE and importantly US approval + reimbursement approvals in US, this ain’t going anywhere. No big pharma is interested. Meanwhile, dilution accelerates in pennies.